𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Folding propensity and biological activity of peptides: New insights from conformational properties of a novel peptide derived from Vitreoscilla haemoglobin

✍ Scribed by A. Bozzi; C. Coccia; A. Di Giulio; A. C. Rinaldi; A. Amadei; G. Mignogna; A. Bonamore; A. Fais; M. Aschi


Publisher
Wiley (John Wiley & Sons)
Year
2007
Tongue
English
Weight
387 KB
Volume
87
Category
Article
ISSN
0006-3525

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The synthetic peptide Vitr‐p‐13 (YPIVGQELLGAIK‐NH~2~), derived from the bacterial dimeric Vitreoscilla haemoglobin (VHb) in the position 95–107, is characterized by a pre‐eminent “statistical coil” conformation in water as demonstrated by CD experiments and long time‐scale MD simulations. In particular, Vitr‐p‐13 does not spontaneously adopt an alpha‐helix folding in water, but it is rather preferentially found in beta‐hairpin‐like conformations. Long time‐scale MD simulations have also shown that Vitr‐p‐13 displays a “topological‐trigger” which initiates alpha‐helix folding within residues 7–10, exactly like seen in the temporins, a group of linear, membrane‐active antimicrobial peptides of similar length. At variance with temporins, in Vitr‐p‐13 such a process is energetically very demanding (+10 kJ/mol) in water at 300 K, and the peptide was found to be unable to bind model membranes in vitro and was devoid of antimicrobial activity. The present results, compared with previous studies on similar systems, strengthen the hypothesis of the requirement of a partial folding when still in aqueous environment to allow a peptide to interact with cell‐membranes and eventually exert membrane perturbation‐related antibiotic effects on target microbial cells. © 2007 Wiley Periodicals, Inc. Biopolymers 87: 85–92, 2007.

This article was originally published online as an accepted preprint. The “Published Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at [email protected]